Panelists Johanna Bendell, MD; Eileen O’Reilly, MD; John Marshall, MD; George Kim, MD; and Caio Max S. Rocha Lima, MD, share their dosing strategies to minimize toxicities in the frontline setting of metastatic pancreatic cancer.
Panelists John Marshall, MD; Tanios Bekaii-Saab, MD; Johanna Bendell, MD; and Alan P. Venook, MD, describe the management of liver-only and liver-dominant metastatic colorectal cancer in the context of curative intent.
Panelists John Marshall, MD; Johanna Bendell, MD; Tanios Bekaii-Saab, MD; and Alan P. Venook, MD, outline the clinical utility of microsatellite instability status and the potential role of immunotherapy in advanced colorectal cancer.
Panelists Johanna Bendell, MD; Caio Max S. Rocha Lima, MD; John Marshall, MD; Eileen O’Reilly, MD; and George Kim, MD, discuss the role of biopsy and molecular profiling in pancreatic cancer and the importance of clinical trial participation.
Panelists John Marshall, MD; Tanios Bekaii-Saab, MD; Johanna Bendell, MD; and Alan P. Venook, MD, provide insight on antibody selection in the frontline and later line settings and the significance of tumor sidedness in advanced colorectal cancer.
To educate viewers on how the study of gene mutations and the use of molecular testing may be used to personalize care for patients with a gastrointestinal cancer, CURE Connections® discusses the concept of precision medicine with experts Michael Pishvaian, MD, PhD and Kennedy Cliffe. Emily Pomeranz, a 3-time cancer survivor, inspires others by explaining how advances in science helped her overcome hospice.
In this CURE Connections® program, Philippa Cheetham, MD, interviews key thought leaders of the GI Cancers Alliance, a coalition of organizations that have joined together to raise awareness, provide education, and accelerate the research and development of treatments in the area of gastrointestinal cancers.
n this special CURE Connections® program, broadcast live at The Ruesch Center for the Cure of GI Cancers, Philippa Cheetham, MD, Martha Raymond, Craig Lustig, and Paula Rothenberg discuss results of a brief survey, conducted by the GI Cancers Alliance, that have helped advocates to better understand the unmet needs of gastrointestinal cancer patients and survivors.
Panelists John Marshall, MD; Alan P. Venook, MD; Tanios Bekaii-Saab, MD; and Johann Bendell, MD, discuss what is known about the clinical significance of left-sided versus right-sided tumors in colorectal cancer.
Dr John Marshall speaks to Dr Thomas Weber at the Ruesch Center Symposium about the increasing incidence of colorectal cancer in young adults and simple steps that clinicians can take to slow this disturbing trend.